But what’s in them? And are they safe?<\/p>\n
Earlier this year, three people in the United States were fined<\/a> thousands of dollars for their role in providing peptide injections, at an anti-aging festival in Las Vegas, to two women who later became critically ill.<\/p>\n The pharmacy board was unable to determine why they got sick, and what precisely the serums contained.<\/p>\n Our work with colleagues at Steroid QNECT<\/a>, a hotline where people can seek confidential advice about enhancement drugs, tells us people are already injecting peptides in Australia.<\/p>\n But regulation is not keeping up. And there are still major gaps in the evidence about whether peptides’ anti-aging claims stack up, and whether they are safe for humans.<\/p>\n What are injectable peptides, and why are they trending?<\/p>\n Peptides are short chains of amino acids \u2013 the building blocks of proteins. They act as chemical messengers in the body and play a key role in many processes. These include helping repair skin and calming inflammation<\/a>.<\/p>\n The body naturally produces peptides. Synthetic peptides are manufactured to mimic or enhance these natural functions.<\/p>\n Certain peptides have clear medical uses. For example, glucagon-like peptide-1 (GLP-1) drugs, such as semaglutide, are approved for diabetes<\/a> and weight management \u2013 sold as Ozempic and Wegovy. This is based on strong clinical trial<\/a> evidence<\/a> they are effective.<\/p>\n But a growing number of peptides are being marketed for cosmetic and anti-aging purposes, without approval from Australia’s therapeutic goods regulator.<\/p>\n Peptides such as GHK-Cu, BPC-157, and TB-500 are sold online with claims they can enhance collagen production, accelerate skin repair, reduce wrinkles, and even reverse aspects of biological aging<\/a>.<\/p>\n Currently, regulated injectable peptides fall under prescription-only<\/a> medicine categories. This means they should only be accessed through a qualified health professional for a legitimate medical indication.<\/p>\n Australian regulators have already issued fines<\/a> to companies for illegally promoting weight-loss injections directly to consumers.<\/p>\n The Therapeutic Goods Administration (TGA) lists other synthetic peptides not yet approved for human consumption, such as BPC-157, as Schedule 4<\/a> poisons.<\/p>\n To get around this, many products circulating online are sold as “research chemicals” labeled “not for human consumption”.<\/p>\n Yet in practice, they are packaged, dosed, and marketed in ways that clearly anticipate<\/a> human use. Online sellers typically require minimal verification of age or identity, and promise rapid shipping and high purity (for example, “99%+ tested”).<\/p>\n This creates a parallel market operating outside clinical oversight and regulatory safeguards. While importing or possessing prescription-only peptides without authority can lead to fines or legal penalties, enforcement is challenging<\/a> in global, digital markets.<\/p>\n At the same time, injecting appears to be becoming less taboo, particularly in the cosmetic and wellness industry. Most cosmetic injectables (including anti-wrinkle injections and dermal fillers) also involve prescription-only substances. Yet there are many clinics<\/a> that offer injections with very little oversight from prescribing doctors.<\/p>\n This broader “injectable culture”, with simultaneous increases in steroid use<\/a>, may be lowering barriers to more experimental practices, including peptide use.<\/p>\n What does the evidence actually say?<\/p>\n For many peptides promoted for anti-aging and skin health, high-quality human evidence remains limited.<\/p>\n Claims peptides such as GHK-Cu, BPC-157, and TB-500 can help regenerate and repair tissue and calm inflammation are based on a handful of laboratory studies \u2013 in cells or animals, not humans.<\/p>\n For example, there is some limited evidence GHK-Cu could play a role<\/a> in collagen production, and wound healing<\/a> in mice. But these findings have not been confirmed in humans.<\/p>\n Similarly, some research<\/a> suggests BPC-157 can promote new blood cell growth, reduce inflammation, and heal tissue in rats.<\/p>\n But human evidence is extremely limited. Only three small studies<\/a> have looked at BPC-157, and these were not well designed, and lacked a control group to compare the reported effects (such as improvement in knee pain). No large clinical trials<\/a> exist. So its safety and effectiveness in humans remain uncertain.<\/p>\n A consistent pattern emerges:<\/p>\n evidence is mostly limited to animal studies So currently, we don’t have enough quality evidence to support the many anti-aging claims made for peptides.<\/p>\n And there are risks<\/p>\n First, there is the issue of unknown product quality. Unregulated peptides may be mislabelled, contaminated, or incorrectly dosed \u2013 a problem already documented<\/a> in adjacent markets, such as counterfeit steroids.<\/p>\n Second, there are biological risks. Peptides that influence growth, repair, or hormonal pathways may also stimulate unintended processes. In theory, this could include promoting the growth of existing tumors<\/a> or disrupting normal endocrine function. This cancer<\/a> risk is amplified by the high presence of heavy metals<\/a> in illicit enhancement drug markets.<\/p>\n Third, injecting carries its own risks \u2013 including infections, abscesses, and tissue damage, particularly when products are self-administered without sterile technique<\/a>.<\/p>\n Related: Here’s The Science on How Peptides Could Boost Your Workout<\/a><\/p>\n At Steroid QNECT<\/a>, we are already seeing people seeking advice after using peptides they bought online \u2013 often unsure what they have taken, how much, or what to expect.<\/p>\n In some cases, dosing far exceeds anything studied in clinical trials.<\/p>\n What needs to change?<\/p>\n We need clearer, more consistent regulation of peptide supply and marketing. But this is unlikely to be enough on its own, given the global and digital reach of peptide supply chains.<\/p>\n A more effective response would also include clear, accessible public health information on the potential benefits and risks of peptide use.<\/p>\n Importantly, responses need to reflect reality: people are already using these substances.<\/p>\n Timothy Piatkowski<\/a>, Senior Research Fellow in Public Health, The University of Queensland<\/a>; Bahareh Ahmadinejad<\/a>, PhD Candidate in Public Health, The University of Queensland<\/a>, and Samuel Cornell<\/a>, Honorary Fellow in Public Health, The University of Queensland<\/a>; UNSW Sydney<\/a><\/p>\n This article is republished from The Conversation<\/a> under a Creative Commons license. Read the original article<\/a>.<\/p>\n \t\t![\"Grid](\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/04\/file-20260407-63-haimbh.png\")
<\/a>Social media influencers are promoting peptides for anti-aging to followers. (TikTok)Are these products legal in Australia?<\/p>\n![\"Subscribe](\"https:\/\/www.newsbeep.com\/nz\/wp-content\/uploads\/2026\/03\/1774966268_752_Generic-Health-Promo-Final-642x273.jpg\")
<\/a><\/p>\n
\nhuman studies, where they exist, are small and short-term
\nthere are no high-quality trials reflecting real-world use, including combinations, higher doses, or long-term administration.<\/p>\n